Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Johnson and Johnson (France)

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. These diseases range from cancer, HIV/AIDS and bacterial infections to schizophrenia, epilepsy, rheumatoid arthritis and psoriasis. In 2007, we invested $5.3 billion in the search for new ways to treat these diseases and many others. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.

These companies are organized into three global business units:

Central Nervous System and Internal Medicine

This business unit develops medicines for an array of health problems, including central nervous system disorders, such as schizophrenia and epilepsy; metabolic diseases, such as diabetes; cardiovascular diseases; and infectious diseases.

B.I.O. (Biotechnology, Immunology & Oncology)

This business unit develops traditional and biologic medicines to treat autoimmune disorders, such as rheumatoid arthritis, psoriasis, and Crohn’s disease; a wide range of cancers; and blood disorders, such as anemia.

Virology

This business unit develops medicines for the treatment of infectious diseases, such as HIV/AIDS, hepatitis C and tuberculosis.


Contact Details:
rue camille desmoulins
issy les moulineaux cedex 9
F-92787
France
Tel:33-155004174
Fax:
Email:
WWW:

www.jnj.com




BioNews Results for Johnson and Johnson (France):

Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion
PR inside:  Nov 20 2009 1:48PM Matching: johnson france
Nice say no to new liver cancer drug
Politics.co.uk:  Nov 19 2009 8:14PM Matching: johnson france
Commercial Insight: Antipsychotics - Revenues Of Depots And New Agents Will Partially Offset Generic Erosion -
OfficialSpin:  Nov 19 2009 2:30PM Matching: johnson france
New study sheds light on potassium pore dynamics and serves as an important foundation for research
News-Medical.Net:  Nov 19 2009 11:35AM Matching: johnson france
No new liver cancer drug for the NHS
Private Healthcare UK:  Nov 19 2009 5:16PM Matching: johnson france
Promote your company here: BioNewsCast - Press Release Distribution

View more Johnson and Johnson (France) news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 5078 times since April 2007, the link to the organisation's website has been followed 190 times

Recent Search Terms used to find this page: johnson and johnson france | johnson and johnson france | johnson johnson france | Johnson Johnson France contact | johnson johnson france | johnson johnson france | jnj france | johnson france | JnJ france news 09 | johnson and johnson france | .

Search for more companies in issy les moulineaux cedex 9

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Johnson and Johnson (France)

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.